Are you Dr. Gibbons?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 85 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Don Gibbons Jr., MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Florida, and Oklahoma. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
- Baylor College of MedicineResidency, Internal Medicine, 2004 - 2006
- Albert Einstein College of MedicineClass of 2004
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2007 - 2024
- OK State Medical License 2020 - 2021
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC). Start of enrollment: 2014 Mar 24
- MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2018 May 01
Publications & Presentations
PubMed
- Anti-tumor activity of a novel LAIR1 antagonist in combination with anti-PD-1 to treat collagen-rich solid tumors.B Leticia Rodriguez, Jiawei Huang, Laura Gibson, Jared J Fradette, Hung-I H Chen, Kikuye Koyano, Czrina Cortez, Betty Li, Carmence Ho, Amir M Ashique, Vicky Y Lin, Suz...> ;Molecular Cancer Therapeutics. 2024 Apr 22
- Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights.Sheeba J Sujit, Muhammad Aminu, Tatiana V Karpinets, Pingjun Chen, Maliazurina B Saad, Morteza Salehjahromi, John D Boom, Mohamed Qayati, James M George, Haley Allen, ...> ;Nature Communications. 2024 Apr 11
- 1 citationsSynthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept.Morteza Salehjahromi, Tatiana V Karpinets, Sheeba J Sujit, Mohamed Qayati, Pingjun Chen, Muhammad Aminu, Maliazurina B Saad, Rukhmini Bandyopadhyay, Lingzhi Hong, Ajay...> ;Cell Reports. Medicine. 2024 Mar 19
- Join now to see all
Press Mentions
- MD Anderson Research Highlights for August 11, 2021August 11th, 2021
- Meet 2019 STAT Wunderkind Limo Chen, Ph.D., of MD Anderson Cancer CenterJanuary 8th, 2020
- Immunotherapy for Lung Cancer: Researchers Working to Broaden Its ReachMay 24th, 2019
- Join now to see all
Grant Support
- Notch And Stem Cells In Lung Cancer Treated With Erlotinib PLUS Notch Inhibitor.National Cancer Institute2011–2012
- Microrna-200 Family Regulation By The Apical-Basal Polarity Complexes In EMT AndNational Cancer Institute2010–2011
Professional Memberships
- Member
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas